Healthcare & Pharmaceuticals

Published by
Coalition Against Bayer Dangers
|
In Bayer and the Global Compact, Phillipp Mimkes of the Coalition Against Bayer Dangers looks at Bayer's corporate history and why it may be at odds with the Compact, a partnership between the UN and big business. Here, Mimkes offers a few more reasons. Read More
Published by
Coalition Against Bayer Dangers
|
By |
Bayer doesn't just make aspirin--it's a major producer of chemicals and drugs with a dubious corporate record. So how did it get into a partnership with the UN? A German activist tells how and why. Read More
Published by
Village Voice
|
By |
Last week, after its findings revealed that the combination of hormones taken by some 6 million women was doing more harm than good, causing an increase in heart attacks, breast cancer, blood clots, and strokes, a national study was halted mid-stream. Wyeth, which has raked in more than $2 billion a year from its top-selling hormone therapies is now watching its stock price dive. Read More
Published by
The Polaris Institute, Council of Canadians, BIOdevastation, et al.
|
Over the last two years, thousands of people have gathered to counter the annual conventions of the biotechnology industry in Boston and San Diego. This year, people will be converging on Toronto to broaden the biojustice movement and challenge the biotechnology industry and their vision for our future. It will be a gathering to learn, strategize and network about genetic engineering in agriculture and pharmaceuticals, biowarfare, genetic and non-genetic discrimination, trade regimes and corporate control, patenting of life and more. This event is timed to challenge the industry's annual convention BIO2002, Toronto, June 9-12. Read More
Published by
IRINNEWS.org
|
JOHANNESBURG -- A severe shortage of two antiretrovirals (ARVs) produced by leading pharmaceutical Bristol-Myers Squibb in Kenya, could have critical repercussions for patients, says Medecines sans Frontieres (MSF). Read More
Published by
Special to CorpWatch
|
By |
From golden rice to anti-viral tomatoes, is the biotech industry's third generation good medicine or good marketing? And, activists ask, what are the environmental consequences? Read More
Published by
Médecins Sans Frontières (Doctors Without Borders)
|
As East African countries are about to change national malaria treatment protocols, Medecins Sans Frontieres (MSF) today releases a report in the hope of averting a fatal choice. Read More
Published by
Asia-Europe Dialogue Project
|
By |
US officials have refused to bust Bayer's monopoly on anthrax drugs, even though generic drugs would save $millions. Bayer's patent was protected under the WTO. Now those rights are challenged. Read More
Published by
Indo Asian News Service
|
By |
NEW DELHI -- The Kerala government has decided to introduce legislation to protect the intellectual property rights of its tribespeople who have been practising traditional nature-based medicine for centuries. Read More
* indicates required